BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14734725)

  • 21. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Good and laudable pus.
    Gorbach SL
    J Clin Invest; 1995 Dec; 96(6):2545. PubMed ID: 8675616
    [No Abstract]   [Full Text] [Related]  

  • 23. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
    Crabb JH; Finberg R; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial structure and functional relation to abscess formation.
    Tzianabos AO; Onderdonk AB; Kasper DL
    Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction of zwitterionic motifs into bacterial polysaccharides generates TLR2 agonists able to activate APCs.
    Gallorini S; Berti F; Parente P; Baronio R; Aprea S; D'Oro U; Pizza M; Telford JL; Wack A
    J Immunol; 2007 Dec; 179(12):8208-15. PubMed ID: 18056364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens.
    Cobb BA; Kasper DL
    Cell Microbiol; 2005 Oct; 7(10):1398-403. PubMed ID: 16153240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6 is essential for zwitterionic polysaccharide-mediated abscess formation.
    Meemboor S; Mertens J; Flenner E; Groneck L; Zingarelli A; Gamstätter T; Bessler M; Seeger JM; Kashkar H; Odenthal M; Kalka-Moll WM
    Innate Immun; 2010 Oct; 16(5):310-21. PubMed ID: 19897529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.
    Taams LS; van Eden W; Wauben MH
    J Immunol; 1999 Feb; 162(4):1974-81. PubMed ID: 9973467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.
    Tzianabos AO; Wang JY; Lee JC
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9365-70. PubMed ID: 11470905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.
    Surana NK; Kasper DL
    Immunol Rev; 2012 Jan; 245(1):13-26. PubMed ID: 22168411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritonitis induced by Bacteroides fragilis.
    Woltmann A; Gangloff SC; Bruch HP; Rietschel ET; Solbach W; Silver J; Goyert SM
    Med Microbiol Immunol; 1999 Mar; 187(3):149-56. PubMed ID: 10206146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.
    Zaleznik DF; Finberg RW; Shapiro ME; Onderdonk AB; Kasper DL
    J Clin Invest; 1985 Mar; 75(3):1023-7. PubMed ID: 2579976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class II MHC: sweetening the peptide only diet?
    Watts C
    Cell; 2004 May; 117(5):558-9. PubMed ID: 15163404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen.
    Li Y; Yang L; Chen S; Zhang Y; Wu X
    Hematology; 2005 Oct; 10(5):387-92. PubMed ID: 16273727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.
    Kasper DL; Onderdonk AB; Bartlett JG
    J Infect Dis; 1977 Dec; 136(6):789-95. PubMed ID: 336801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells.
    Taams LS; Boot EP; van Eden W; Wauben MH
    J Autoimmun; 2000 Jun; 14(4):335-41. PubMed ID: 10882060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of Genes Encoding Putative Zwitterionic Capsular Polysaccharides of Diverse Intestinal Bacteroides Reduces the Induction of Host Anti-Inflammatory Factors.
    Arnolds KL; Yamada E; Neff CP; Schneider JM; Palmer BE; Lozupone CA
    Microb Ecol; 2023 May; 85(4):1620-1629. PubMed ID: 35596750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.